News Focus
News Focus
icon url

semi_infinite

03/06/18 3:15 PM

#217730 RE: DewDiligence #217729

Thx. I saw the JV with Genentech. The note made it sound like CRVS was directly involved with MRK the source being MRK's powerpoint.
icon url

jbog

03/06/18 4:05 PM

#217731 RE: DewDiligence #217729

The best I can find is that Merck acquired Preladenant through the Schering-Plough acquisition.


icon url

DewDiligence

03/08/18 10:53 AM

#217770 RE: DewDiligence #217729

CRVS sells 8.12M* shares @8.50—an 11% discount to yesterday’s close:

https://finance.yahoo.com/news/corvus-pharmaceuticals-announces-pricing-public-140442703.html

*Assuming exercise of underwriter’s option.